These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 21820996)

  • 1. Flow cytometry: an alternative method for direct quantification of antigens adsorbed to aluminum hydroxide adjuvant.
    Ugozzoli M; Laera D; Nuti S; Skibinski DA; Bufali S; Sammicheli C; Tavarini S; Singh M; O'Hagan DT
    Anal Biochem; 2011 Nov; 418(2):224-30. PubMed ID: 21820996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of aluminum-containing adjuvants in antigen internalization by dendritic cells in vitro.
    Morefield GL; Sokolovska A; Jiang D; HogenEsch H; Robinson JP; Hem SL
    Vaccine; 2005 Feb; 23(13):1588-95. PubMed ID: 15694511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between the strength of antigen adsorption to an aluminum-containing adjuvant and the immune response.
    Hansen B; Sokolovska A; HogenEsch H; Hem SL
    Vaccine; 2007 Sep; 25(36):6618-24. PubMed ID: 17681647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of antigen-binding to aluminum adjuvants and the immune response with a novel phosphonate linker.
    Lu F; Boutselis I; Borch RF; Hogenesch H
    Vaccine; 2013 Sep; 31(40):4362-7. PubMed ID: 23887038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation of botulinum neurotoxin heavy chain fragments for vaccine development: mechanisms of adsorption to an aluminum-containing adjuvant.
    DePaz RA; Henderson I; Advant SJ
    Vaccine; 2005 Jul; 23(31):4029-35. PubMed ID: 15963360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NaCl strongly modifies the physicochemical properties of aluminum hydroxide vaccine adjuvants.
    Art JF; Vander Straeten A; Dupont-Gillain CC
    Int J Pharm; 2017 Jan; 517(1-2):226-233. PubMed ID: 27956190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the strength of adsorption of hepatitis B surface antigen to aluminum hydroxide adjuvant on the immune response.
    Hansen B; Belfast M; Soung G; Song L; Egan PM; Capen R; Hogenesch H; Mancinelli R; Hem SL
    Vaccine; 2009 Feb; 27(6):888-92. PubMed ID: 19071182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune response to antigen adsorbed to aluminum hydroxide particles: Effects of co-adsorption of ALF or ALFQ adjuvant to the aluminum-antigen complex.
    Beck Z; Torres OB; Matyas GR; Lanar DE; Alving CR
    J Control Release; 2018 Apr; 275():12-19. PubMed ID: 29432824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant properties of meningococcal outer membrane vesicles and the use of adjuvants in Neisseria meningitidis protein vaccines.
    Sanders H; Feavers IM
    Expert Rev Vaccines; 2011 Mar; 10(3):323-34. PubMed ID: 21434800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of adsorbed antigen in mono-valent and combination vaccines.
    Morefield GL; HogenEsch H; Robinson JP; Hem SL
    Vaccine; 2004 May; 22(15-16):1973-84. PubMed ID: 15121310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of microenvironment pH of aluminum hydroxide adjuvant on the chemical stability of adsorbed antigen.
    Wittayanukulluk A; Jiang D; Regnier FE; Hem SL
    Vaccine; 2004 Mar; 22(9-10):1172-6. PubMed ID: 15003645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of Protein Content in Alhydrogel
    Rausch KM; Zhu D
    Methods Mol Biol; 2017; 1494():263-271. PubMed ID: 27718200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative Analysis of Vaccine Antigen Adsorption to Aluminum Adjuvant Using an Automated High-Throughput Method.
    Ahl PL; Wang SC; Chintala R; Mensch C; Smith WJ; Wenger M; Blue J
    PDA J Pharm Sci Technol; 2018; 72(2):149-162. PubMed ID: 29343619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of aluminium hydroxide and meningococcal serogroup C capsular polysaccharide on the immunogenicity and reactogenicity of a group B Neisseria meningitidis outer membrane vesicle vaccine.
    Rosenqvist E; Høiby EA; Bjune G; Aase A; Halstensen A; Lehmann AK; Paulssen J; Holst J; Michaelsen TE; Nøkleby H; Frøholm LO; Closs O
    Dev Biol Stand; 1998; 92():323-33. PubMed ID: 9554288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of a quartz crystal microbalance platform to study protein adsorption on aluminum hydroxide vaccine adjuvants: Focus on phosphate-hydroxide ligand exchanges.
    Art JF; Soumillion P; Dupont-Gillain CC
    Int J Pharm; 2020 Jan; 573():118834. PubMed ID: 31715342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of immunopotentiation by aluminum-containing adjuvants elucidated by the relationship between antigen retention at the inoculation site and the immune response.
    Noe SM; Green MA; HogenEsch H; Hem SL
    Vaccine; 2010 Apr; 28(20):3588-94. PubMed ID: 20211692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Aluminum Adjuvant and Preservatives on Structural Integrity and Physicochemical Stability Profiles of Three Recombinant Subunit Rotavirus Vaccine Antigens.
    Agarwal S; Hickey JM; McAdams D; White JA; Sitrin R; Khandke L; Cryz S; Joshi SB; Volkin DB
    J Pharm Sci; 2020 Jan; 109(1):476-487. PubMed ID: 31589875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spectroscopic characterization of antibodies adsorbed to aluminium adjuvants: correlation with antibody vaccine immunogenicity.
    Capelle MA; Brügger P; Arvinte T
    Vaccine; 2005 Feb; 23(14):1686-94. PubMed ID: 15705473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physiochemical and functional characterization of antigen proteins eluted from aluminum hydroxide adjuvant.
    Hutcheon CJ; Becker JO; Russell BA; Bariola PA; Peterson GJ; Stroop SD
    Vaccine; 2006 Nov; 24(49-50):7214-25. PubMed ID: 16860908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of aluminum hydroxide adjuvant and formaldehyde in the formulation of rPA anthrax vaccine.
    Little SF; Ivins BE; Webster WM; Norris SL; Andrews GP
    Vaccine; 2007 Apr; 25(15):2771-7. PubMed ID: 17240008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.